Equity (Tables)

9 Months Ended

Jun. 30, 2023

Equity [Abstract]

Schedule of Stock-based Compensation Expense - By Award Type

The following table sets forth stock-based compensation expense by award type:

	Three Months Ended June 30,				Nine Months Ended June 30,
(in thousands)	2023		2022		2023		2022
RSUs and RSAs	$	1,113	$	692	$	2,869	$	1,795
PSUs and PRSAs	517		708		1,818		1,602
Outside director equity awards and fees in common stock	83		123		295		358
Total stock-based compensation expense	$	1,713	$	1,523	$	4,982	$	3,755

Schedule of Stock-based Compensation Expense - By Expense Type

The following table sets forth stock-based compensation expense by expense type:

	Three Months Ended June 30,				Nine Months Ended June 30,
(in thousands)	2023		2022		2023		2022
Cost of revenue	$	436	$	275	$	1,154	$	604
Selling, general, and administrative	980		1,001		3,006		2,537
Research and development	297		247		822		614
Total stock-based compensation expense	$	1,713	$	1,523	$	4,982	$	3,755

Schedule of (Loss) Income Per Share

The following table sets forth the computation of basic and diluted net loss per share:

	Three Months Ended June 30,				Nine Months Ended June 30,
(in thousands, except per share data)	2023		2022		2023		2022
Numerator
Net loss	$	(9,857)	$	(7,649)	$	(33,778)	$	(7,460)
Denominator
Weighted average number of shares outstanding - basic	53,926		37,425		45,546		37,197
Effect of dilutive securities
Stock options	—		—		—		—
PSUs, RSUs, and restricted stock	—		—		—		—
Weighted average number of shares outstanding - diluted	53,926		37,425		45,546		37,197
Earnings per share - basic	$	(0.18)	$	(0.20)	$	(0.74)	$	(0.20)
Earnings per share - diluted	$	(0.18)	$	(0.20)	$	(0.74)	$	(0.20)
Weighted average antidilutive options, unvested RSUs and RSAs, and unvested PSUs excluded from the computation	3,823		3,163		2,533		1,315

Schedule of Common Stock Reserved for Future Issuances

Common stock reserved for future issuances as of June 30, 2023 was as follows:

	Amount
Exercise of outstanding stock options	9,981
Unvested RSUs and RSAs	4,491,733
Unvested PSUs and PRSAs (at 100% maximum payout)	1,750,068
Issuance of stock-based awards under the Equity Plans	599,585
Purchases under the officer and director share purchase plan	88,741
Total reserved	6,940,108